Department of Reproductive Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Biomed Res Int. 2023 Feb 13;2023:1508675. doi: 10.1155/2023/1508675. eCollection 2023.
Hyperandrogenaemia and insulin resistance (IR) are the main characteristics of polycystic ovary syndrome (PCOS). Here, we study to find appropriate markers predicting IR and hyperandrogenaemia of women with PCOS in northwest China.
According to body mass index (BMI), 953 patients with PCOS were divided into two groups. All the patients underwent physical examination and ultrasonography and collected elbow vein blood. Their BMI, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), LAP, VAI, homeostasis model assessment index of insulin resistance (HOMA-IR), and free androgen index (FAI) were calculated. Each group (normal weight and obesity/overweight) was further divided into two subgroups according to their HOMA-IR and FAI: the IR+ subgroup/IR- subgroup and FAI+ subgroup/FAI- subgroup. Furthermore, we compared the clinical indices, hormone levels, and metabolic makers separately between these groups. The correlations between these parameters and HOMA-IR or FAI were tested; sensitivity, specificity, and receiver-operating characteristic (ROC) curves were calculated.
In the obesity/overweight group, the VAI (best cut-off value: 2.27, area under the curve (AUC) = 0.699) and LAP (best cut-off value: 45.54, AUC = 0.680) were sensitive predictors of IR (sensitivity = 72% and sensitivity = 67%). Additionally, the VAI (best cut-off value: 2.13, AUC = 0.624) and LAP (best cut-off value: 51.18, AUC = 0.582) were sensitive predictors of FAI (sensitivity = 87% and sensitivity = 64%). In the normal weight group, BMI could preferably predict HOMA-IR (AUC = 0.717, best cut-off value: 21.62) and HOMA-IR could preferably predict FAI (best cut-off value: 2.11, AUC = 0.648).
Our data indicated that the VAI and LAP may contribute to the early identification of IR and hyperandrogenaemia in the obesity/overweight patients of PCOS. In normal weight PCOS, BMI was a better predictor to IR, and HOWA-IR was a better predictor to FAI.
高雄激素血症和胰岛素抵抗(IR)是多囊卵巢综合征(PCOS)的主要特征。在这里,我们研究了在中国西北地区寻找预测 PCOS 妇女 IR 和高雄激素血症的合适标志物。
根据体重指数(BMI),将 953 例 PCOS 患者分为两组。所有患者均进行体格检查和超声检查,并采集肘静脉血。计算 BMI、腰高比(WHtR)、腰臀比(WHR)、LAP、VAI、胰岛素抵抗的稳态模型评估指数(HOMA-IR)和游离雄激素指数(FAI)。根据 HOMA-IR 和 FAI 将每组(正常体重和肥胖/超重)进一步分为 IR+亚组/IR-亚组和 FAI+亚组/FAI-亚组。此外,我们分别比较了这些组之间的临床指标、激素水平和代谢标志物。测试了这些参数与 HOMA-IR 或 FAI 之间的相关性;计算了敏感性、特异性和受试者工作特征(ROC)曲线。
在肥胖/超重组中,VAI(最佳截断值:2.27,AUC=0.699)和 LAP(最佳截断值:45.54,AUC=0.680)是 IR 的敏感预测因子(敏感性=72%和敏感性=67%)。此外,VAI(最佳截断值:2.13,AUC=0.624)和 LAP(最佳截断值:51.18,AUC=0.582)是 FAI 的敏感预测因子(敏感性=87%和敏感性=64%)。在正常体重组中,BMI 可以更好地预测 HOMA-IR(AUC=0.717,最佳截断值:21.62),HOMA-IR 可以更好地预测 FAI(最佳截断值:2.11,AUC=0.648)。
我们的数据表明,VAI 和 LAP 可能有助于识别肥胖/超重 PCOS 患者的 IR 和高雄激素血症。在正常体重的 PCOS 中,BMI 是 IR 的更好预测因子,HOMA-IR 是 FAI 的更好预测因子。